Advancing Care Delivery to Improve Cardiovascular and Renal Outcomes in High-Risk Patients with Type 2 Diabetes
Evidence-based Management of T2D with ASCVD, CKD, or HF
Release date: March 31, 2022
Expiration date: March 31, 2023
Estimated Time of Completion: 30 minutes
Description
Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control. The Advancing Care Delivery to Improve Cardiovascular and Renal Outcomes in High-Risk Patients with Type 2 Diabetes online series will increase health care professional’s level of confidence in assessing their patients’ profile and needs, improve their knowledge of the available T2D treatment options (to include novel agents), and enhance their ability to educate, inform, and treat at-risk patients by pursuing the most effective (and guideline recommended) treatment plans.
Watch SGLT-2 Inhibitors webcast for a review of the risks and benefits of SGLT-2 inhibitors and how they can be incorporated into existing diabetes regimens for patients. . Using current evidence-based data, American Diabetes Association (ADA) guidelines regarding the use of SGLT-2 inhibitors will be discussed.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
Kevin M. Pantalone, DO | |
Astra Zeneca | Consulting Teaching and Speaking |
Eli Lilly | Consulting |
Merck & Co, Inc. | Consulting Research support Teaching and Speaking |
Novo Nordisk, Inc. | Consulting Research Support Teaching and Speaking |
Sanofi Aventis | Consulting |
Corcept | Consulting Teaching and Speaking |
Bayer | Consulting Research / Independent Contractor |
Diasome, Inc. | Consulting |
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Vinni Makin, MD
Pratibha PR Rao, MD, MPH
Acknowledgement
The Cleveland Clinic Foundation Center for Continuing Education acknowledges an educational grant for support of the Internet Enduring activity from:
Lilly USA, LLC
Merck Sharp & Dohme Corp
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education and Endocrinology and Metabolism Institute.